Observation of Treatment Patterns With Lucentis in Approved Indications

NCT02194803 · clinicaltrials.gov ↗

COMPLETED

Status

5778

Enrollment

INDUSTRY

Sponsor class

Conditions

Neovascular AMD, Visual Impairment Due to DME, Visual Impairment Due to Macular Oedema Secondary to Branch or Central RVO, Visual Impairment Due to CNV

Sponsor

Novartis Pharmaceuticals